Boehringer collaborates with Autifony on schizophrenia drug
Deal could be worth 627.5 million euros
X
Boehringer collaborates with Autifony on schizophrenia drug
https://pharmaphorum.com/news/boehringer-collaborates-autifony-schizophrenia-drug/
Deal could be worth 627.5 million euros